Skip to content


Journal for ImmunoTherapy of Cancer


Section edited by Christian Capitini, MD

Reaction to and/or perspectives on significant events in the field in the basic science area. May address a critical challenge, elaborate or extend a conversation of a focal article, provide an application of a theoretical perspective, or shed light on a particular issue in the field.

Previous Page Page 2 of 2 Next Page
  1. Content type: Commentary

    Attention has recently focused on new cancer immunotherapy protocols aiming to activate T cell mediated anti-tumor responses. To this end, administration of antibodies that target inhibitory molecules regulati...

    Authors: Per thor Straten and Federico Garrido

    Citation: Journal for ImmunoTherapy of Cancer 2016 4:23

    Published on:

  2. Content type: Commentary

    The innate and adaptive immune systems have evolved together to fight infection and cancerous tissues. The innate immune system emerges first with the adaptive immune system following, both ostensibly being br...

    Authors: Carolyn Rosinsky and Paul Andrew Antony

    Citation: Journal for ImmunoTherapy of Cancer 2016 4:16

    Published on:

  3. Content type: Commentary

    Reliable mouse models are key in the discovery and development of novel anticancer treatments. Non-invasive monitoring techniques such as bioluminescence imaging (BLI) are useful tools to determine tumor engra...

    Authors: Thaïs Baert, Tina Verschuere, Anaïs Van Hoylandt, Rik Gijsbers, Ignace Vergote and An Coosemans

    Citation: Journal for ImmunoTherapy of Cancer 2015 3:57

    Published on:

Previous Page Page 2 of 2 Next Page

2016 Journal Metrics

  • Speed
    27 days from submission to first decision
    11 days from acceptance to publication

    1157.0 Usage Factor

    Social Media Impact
    114 mentions